Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Misonix stock

Own Misonix stock in just a few minutes.

Misonix, Inc is a medical devices business based in the US. Misonix shares (MSON) are listed on the NASDAQ and all prices are listed in US Dollars. Misonix employs 254 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Misonix

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MSON – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Misonix share price

Use our graph to track the performance of MSON stocks over time.

Misonix shares at a glance

Information last updated 2021-04-23.
52-week range$9.06 - $20.68
50-day moving average $19.39
200-day moving average $15.19
Wall St. target price$21.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.79

Buy Misonix shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Misonix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Misonix financials

Revenue TTM $67.6 million
Gross profit TTM $43.7 million
Return on assets TTM -4.26%
Return on equity TTM -15.11%
Profit margin -30.13%
Book value $8.17
Market capitalisation $332.9 million

TTM: trailing 12 months

Shorting Misonix shares

There are currently 366,478 Misonix shares held short by investors – that's known as Misonix's "short interest". This figure is 3.3% down from 378,879 last month.

There are a few different ways that this level of interest in shorting Misonix shares can be evaluated.

Misonix's "short interest ratio" (SIR)

Misonix's "short interest ratio" (SIR) is the quantity of Misonix shares currently shorted divided by the average quantity of Misonix shares traded daily (recently around 70612.331406551). Misonix's SIR currently stands at 5.19. In other words for every 100,000 Misonix shares traded daily on the market, roughly 5190 shares are currently held short.

However Misonix's short interest can also be evaluated against the total number of Misonix shares, or, against the total number of tradable Misonix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Misonix's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Misonix shares in existence, roughly 20 shares are currently held short) or 0.0302% of the tradable shares (for every 100,000 tradable Misonix shares, roughly 30 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Misonix.

Find out more about how you can short Misonix stock.

Misonix share dividends

We're not expecting Misonix to pay a dividend over the next 12 months.

Have Misonix's shares ever split?

Misonix's shares were split on a 3:2 basis on 20 October 1997. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Misonix shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Misonix shares which in turn could have impacted Misonix's share price.

Misonix share price volatility

Over the last 12 months, Misonix's shares have ranged in value from as little as $9.0565 up to $20.68. A popular way to gauge a stock's volatility is its "beta".

MSON.US volatility(beta: 1.45)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Misonix's is 1.4523. This would suggest that Misonix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Misonix overview

Misonix, Inc. , together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site